Biotechnology Stocks
Some of the top Biotechnology stocks now:
Vertex Pharmaceuticals Inc (VRTX -1.77%), Moderna, Inc. Common Stock (MRNA -7.82%), Regeneron Pharmaceuticals Inc (REGN -0.70%), argenx SE American Depositary Shares (ARGX -3.21%).
The table below shows a total of 594 Biotechnology stocks, each contributes to the landscape of the Biotechnology industry. You can easily customize the table by ranking stocks based on price, volume or market cap according to your specific investing preferences.
| Symbol | Name |
Price
(After Hours |
% (1D) | Volume | Market Cap | Price Chart (1D) â–¾ | |
|---|---|---|---|---|---|---|---|
|
Vertex Pharmaceuticals Inc
|
499.74
|
-1.77% |
1.41M |
126.66B |
|
||
|
Moderna, Inc. Common Stock
|
218.01
|
-7.82% |
21.35M |
87.04B |
|
||
|
Regeneron Pharmaceuticals Inc
|
790.74
|
-0.70% |
649.30K |
81.41B |
|
||
|
argenx SE American Depositary Shares
|
819.14
|
-3.21% |
388.97K |
51.51B |
|
||
|
BeOne Medicines Ltd. American Depositary Shares
|
369.06
|
-1.34% |
422.24K |
41.75B |
|
||
|
Revolution Medicines, Inc. Common Stock
|
177.96
|
-5.97% |
2.97M |
38.14B |
|
||
|
Alnylam Pharmaceuticals, Inc.
|
231.83
|
-0.94% |
1.40M |
31.02B |
|
||
|
Royalty Pharma plc Class A Ordinary Shares
|
60.96
|
+2.25% |
5.79M |
27.14B |
|
||
|
Roivant Sciences Ltd. Common Shares
|
33.53
|
-1.50% |
4.92M |
24.22B |
|
||
|
Incyte Genomics Inc
|
113.07
|
-0.18% |
1.58M |
22.92B |
|
||
|
Genmab A/S ADS
|
37.00
|
-2.17% |
2.68M |
22.75B |
|
||
|
BioNTech SE American Depositary Share
|
87.71
|
-2.76% |
1.10M |
22.03B |
|
||
|
Insmed, Inc.
|
96.27
|
-2.96% |
2.40M |
21.02B |
|
||
|
Exelixis Inc
|
62.23
|
-0.95% |
2.64M |
15.42B |
|
||
|
Ascendis Pharma A/S Ordinary Share
|
225.25
|
-0.60% |
680.31K |
14.82B |
|
||
|
Halozyme Therapeutics, Inc.
|
121.84
|
+0.27% |
2.08M |
13.83B |
|
||
|
Jazz Pharmaceuticals, Inc.
|
210.23
|
-1.95% |
636.18K |
13.65B |
|
||
|
BridgeBio Pharma, Inc. Common Stock
|
66.39
|
-1.10% |
2.06M |
12.98B |
|
||
|
Corcept Therapeutics Inc.
|
110.16
|
-2.83% |
849.64K |
11.91B |
|
||
|
Summit Therapeutics Inc. Common Stock
|
14.63
|
-4.81% |
4.31M |
11.67B |
|
||
|
Bio-Techne Corp.
|
72.57
|
+0.07% |
2.65M |
11.38B |
|
||
|
BioMarin Pharmaceuticals Inc
|
54.68
|
-2.44% |
2.62M |
10.58B |
|
||
|
Madrigal Pharmaceuticals, Inc. Common Stock
|
449.74
|
-2.19% |
364.53K |
10.39B |
|
||
|
Vaxcyte, Inc. Common Stock
|
63.62
|
-2.53% |
3.37M |
10.01B |
|
||
|
ImmunityBio, Inc. Common Stock
|
9.18
|
-8.20% |
21.43M |
9.73B |
|
||
|
Krystal Biotech, Inc. Common Stock
|
316.58
|
-4.07% |
226.11K |
9.37B |
|
||
|
Twist Bioscience Corporation Common Stock
|
132.75
|
-8.13% |
2.82M |
8.80B |
|
||
|
Kymera Therapeutics, Inc. Common Stock
|
104.78
|
-3.11% |
488.56K |
8.71B |
|
||
|
Caris Life Sciences, Inc. Common Stock
|
30.56
|
-3.78% |
2.72M |
8.64B |
|
||
|
Cytokinetics Inc.
|
61.95
|
-3.08% |
1.20M |
8.61B |
|
||
|
Protagonist Therapeutics, Inc
|
128.75
|
-5.71% |
886.73K |
8.33B |
|
||
|
TG Therapeutics, Inc.
|
53.97
|
-3.62% |
1.77M |
8.26B |
|
||
|
Axsome Therapeutics, Inc
|
157.14
|
-2.87% |
873.08K |
8.23B |
|
||
|
ARROWHEAD PHARMACEUTICALS, INC.
|
55.90
|
-4.44% |
1.77M |
7.90B |
|
||
|
Abivax SA American Depositary Shares
|
88.13
|
-4.60% |
1.30M |
7.69B |
|
||
|
Spyre Therapeutics, Inc. Common Stock
|
79.90
|
-0.25% |
1.27M |
7.47B |
|
||
|
Ionis Pharmaceuticals, Inc. Common Stock
|
42.94
|
-2.67% |
1.67M |
7.14B |
|
||
|
Praxis Precision Medicines, Inc. Common Stock
|
241.76
|
-2.61% |
499.62K |
6.75B |
|
||
|
Iovance Biotherapeutics, Inc. Common Stock
|
13.62
|
-7.47% |
12.15M |
6.17B |
|
||
|
Rhythm Pharmaceuticals, Inc. Common Stock
|
86.17
|
-2.05% |
364.06K |
5.93B |
|
||
|
Ligand Pharmaceuticals Inc.
|
295.54
|
-0.99% |
164.50K |
5.89B |
|
||
|
Belite Bio, Inc American Depositary Shares
|
142.78
|
-6.45% |
177.23K |
5.75B |
|
||
|
Immunovant, Inc. Common Stock
|
26.73
|
-2.84% |
1.46M |
5.52B |
|
||
|
Kodiak Sciences Inc Common Stock
|
85.75
|
-2.69% |
1.12M |
5.39B |
|
||
|
CG Oncology, Inc. Common stock
|
59.85
|
-3.25% |
1.08M |
5.31B |
|
||
|
Mirum Pharmaceuticals, Inc. Common Stock
|
80.14
|
-2.73% |
462.92K |
5.20B |
|
||
|
Cogent Biosciences, Inc. Common Stock
|
29.52
|
+0.03% |
2.78M |
5.12B |
|
||
|
PTC Therapeutics, Inc.
|
59.24
|
-2.87% |
787.55K |
4.94B |
|
||
|
Scholar Rock Holding Corporation Common Stock
|
39.90
|
-1.82% |
2.89M |
4.86B |
|
||
|
Oruka Therapeutics, Inc. Common Stock
|
71.93
|
-2.63% |
1.38M |
4.76B |
|
||
|
CRISPR Therapeutics AG
|
49.25
|
-4.41% |
1.52M |
4.76B |
|
||
|
Erasca, Inc. Common Stock
|
13.39
|
-9.95% |
7.09M |
4.68B |
|
||
|
Travere Therapeutics, Inc. Common Stock
|
49.60
|
-6.04% |
1.64M |
4.68B |
|
||
|
Veradermics, Incorporated
|
108.82
|
-5.43% |
670.50K |
4.55B |
|
||
|
Definium Therapeutics, Inc. Common Shares
|
32.10
|
-6.30% |
1.93M |
4.31B |
|
||
|
Edgewise Therapeutics, Inc. Common Stock
|
37.19
|
-2.64% |
1.14M |
4.04B |
|
||
|
Dianthus Therapeutics, Inc. Common Stock
|
72.09
|
-3.27% |
1.05M |
4.03B |
|
||
|
AbCellera Biologics Inc. Common Shares
|
11.80
|
-6.94% |
4.10M |
3.82B |
|
||
|
Tango Therapeutics, Inc.
|
22.04
|
-2.91% |
3.69M |
3.72B |
|
||
|
Telix Pharmaceuticals Limited American Depositary Shares
|
10.69
|
+1.14% |
324.83K |
3.63B |
|
||
|
Arcutis Biotherapeutics, Inc. Common Stock
|
28.82
|
-0.96% |
1.73M |
3.62B |
|
||
|
Legend Biotech Corporation American Depositary Shares
|
18.48
|
-6.67% |
2.96M |
3.59B |
|
||
|
Relay Therapeutics, Inc. Common Stock
|
16.28
|
-5.90% |
2.37M |
3.57B |
|
||
|
Acadia Pharmaceuticals Inc.
|
19.12
|
-2.99% |
1.67M |
3.29B |
|
||
|
Xenon Pharmaceuticals Inc
|
33.49
|
-2.45% |
1.07M |
3.24B |
|
||
|
Viking Therapeutics, Inc
|
25.17
|
-8.04% |
7.56M |
3.20B |
|
||
|
Tarsus Pharmaceuticals, Inc. Common Stock
|
68.07
|
-4.11% |
2.43M |
3.19B |
|
||
|
IDEAYA Biosciences, Inc. Common Stock
|
32.85
|
-2.95% |
654.77K |
3.17B |
|
||
|
Arcus Biosciences, Inc.
|
22.12
|
-3.07% |
1.42M |
2.82B |
|
||
|
Denali Therapeutics Inc. Common Stock
|
17.61
|
-3.98% |
2.30M |
2.81B |
|
||
|
Parabilis Medicines, Inc. Common Stock
|
22.75
|
-9.65% |
1.11M |
2.81B |
|
||
|
Celcuity Inc. Common Stock
|
56.58
|
-6.17% |
4.31M |
2.77B |
|
||
|
Enliven Therapeutics, Inc. Common Stock
|
37.32
|
-5.11% |
1.19M |
2.73B |
|
||
|
Nurix Therapeutics, Inc. Common stock
|
24.42
|
-2.12% |
3.69M |
2.67B |
|
||
|
Dyne Therapeutics, Inc. Common Stock
|
14.25
|
-6.80% |
2.86M |
2.66B |
|
||
|
Zai Lab Limited American Depositary Shares
|
23.19
|
-1.36% |
843.21K |
2.60B |
|
||
|
Beam Therapeutics Inc. Common Stock
|
23.47
|
-5.10% |
1.65M |
2.42B |
|
||
|
ADMA Biologics, Inc.
|
10.68
|
-0.47% |
3.07M |
2.39B |
|
||
|
MBX Biosciences, Inc. Common Stock
|
49.61
|
-2.17% |
818.91K |
2.39B |
|
||
|
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
19.83
|
-3.83% |
1.94M |
2.37B |
|
||
|
Precigen, Inc. Common Stock
|
6.385
|
-11.26% |
5.48M |
2.29B |
|
||
|
Harmony Biosciences Holdings, Inc. Common Stock
|
37.95
|
-0.84% |
892.25K |
2.21B |
|
||
|
Aurinia Pharmaceuticals Inc
|
16.51
|
-1.32% |
736.08K |
2.20B |
|
||
|
Disc Medicine, Inc. Common Stock
|
56.84
|
+0.34% |
560.58K |
2.18B |
|
||
|
Celldex Therapeutics, Inc
|
27.53
|
-4.84% |
997.95K |
2.16B |
|
||
|
Viridian Therapeutics, Inc. Common Stock
|
19.03
|
-2.71% |
2.46M |
2.16B |
|
||
|
Fortrea Holdings Inc. Common Stock
|
22.49
|
-1.12% |
1.84M |
2.14B |
|
||
|
Vericel Corporation
|
40.13
|
-2.17% |
737.13K |
2.05B |
|
||
|
SELLAS Life Sciences Group, Inc. Common Stock
|
9.98
|
-11.99% |
15.76M |
2.02B |
|
||
|
Vera Therapeutics, Inc. Class A Common Stock
|
27.88
|
-2.42% |
1.29M |
2.01B |
|
||
|
Lakefront Biotherapeutics American Depositary Shares
|
29.90
|
-0.10% |
250.89K |
1.96B |
|
||
|
Pharvaris N.V. Ordinary Shares
|
27.74
|
-6.41% |
1.31M |
1.95B |
|
||
|
Immunome, Inc.
|
16.47
|
-5.34% |
1.30M |
1.94B |
|
||
|
ADARx Pharmaceuticals, Inc. Common Stock
|
17.65
|
-0.28% |
247.03K |
1.89B |
|
||
|
Agios Pharmaceuticals, Inc.
|
31.32
|
-3.09% |
952.66K |
1.87B |
|
||
|
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
3.465
|
-16.71% |
40.50M |
1.86B |
|
||
|
Novavax Inc
|
11.26
|
-12.17% |
9.87M |
1.86B |
|
||
|
Sarepta Therapeutics,, Inc. Common Stock
|
17.10
|
-3.88% |
9.86M |
1.81B |
|
||
|
Zymeworks Inc.
|
25.03
|
-2.80% |
631.86K |
1.80B |
|
||
|
Mineralys Therapeutics, Inc. Common Stock
|
20.30
|
-6.19% |
1.18M |
1.79B |
|
||
|
Palvella Therapeutics, Inc. Common Stock
|
120.30
|
-5.53% |
179.49K |
1.73B |
|
||
|
Mesoblast Limited American Depositary Shares
|
13.28
|
-4.80% |
615.69K |
1.72B |
|
||
|
Xencor, Inc.
|
22.85
|
-4.79% |
1.13M |
1.70B |
|
||
|
Septerna, Inc. Common Stock
|
36.35
|
-2.94% |
234.12K |
1.70B |
|
||
|
Trevi Therapeutics, Inc. Common Stock
|
11.88
|
-1.90% |
2.70M |
1.69B |
|
||
|
UroGen Pharma Ltd. Ordinary Shares
|
34.56
|
-5.60% |
1.05M |
1.69B |
|
||
|
Vir Biotechnology, Inc. Common Stock
|
9.96
|
-4.87% |
1.73M |
1.69B |
|
||
|
Braveheart Bio, Inc. Common Stock
|
18.71
|
-4.30% |
414.85K |
1.68B |
|
||
|
Biohaven Ltd.
|
10.78
|
-5.69% |
2.42M |
1.63B |
|
||
|
Zenas BioPharma, Inc. Common Stock
|
24.84
|
-2.20% |
661.65K |
1.62B |
|
||
|
Intellia Therapeutics, Inc
|
11.42
|
+0.71% |
8.22M |
1.60B |
|
||
|
Nuvation Bio Inc.
|
4.45
|
-6.32% |
4.47M |
1.56B |
|
||
|
Stoke Therapeutics, Inc. Common Stock
|
24.17
|
-1.79% |
880.12K |
1.56B |
|
||
|
Generate Biomedicines, Inc. Common Stock
|
12.09
|
-7.43% |
1.07M |
1.55B |
|
||
|
Maze Therapeutics, Inc. Common Stock
|
27.53
|
+0.18% |
1.02M |
1.53B |
|
||
|
Immunocore Holdings plc American Depositary Shares
|
29.40
|
-0.27% |
924.92K |
1.51B |
|
||
|
uniQure N.V.
|
21.78
|
-3.29% |
1.29M |
1.51B |
|
||
|
Ocular Therapeutix, Inc.
|
6.87
|
-6.91% |
2.76M |
1.51B |
|
||
|
Structure Therapeutics Inc. American Depositary Shares
|
21.08
|
-5.00% |
1.16M |
1.50B |
|
||
|
Innoviva, Inc. Common Stock
|
20.78
|
-0.38% |
550.48K |
1.50B |
|
||
|
Korsana Biosciences, Inc. Common Stock
|
32.38
|
-3.77% |
112.92K |
1.47B |
|
||
|
Kailera Therapeutics, Inc. Common Stock
|
11.25
|
-3.93% |
1.30M |
1.46B |
|
||
|
Ascentage Pharma Group International American Depository Shares
|
15.37
|
+4.63% |
15,091 |
1.44B |
|
||
|
Ultragenyx Pharmaceutical Inc.
|
14.54
|
-4.15% |
2.92M |
1.43B |
|
||
|
Absci Corporation Common Stock
|
8.25
|
-7.09% |
3.53M |
1.42B |
|
||
|
Hemab Therapeutics Holdings, Inc. Common Stock
|
30.07
|
-7.53% |
351.76K |
1.40B |
|
||
|
AnaptysBio, Inc. Common Stock
|
46.61
|
-4.31% |
413.64K |
1.39B |
|
||
|
Rapport Therapeutics, Inc. Common Stock
|
27.57
|
-6.76% |
411.26K |
1.32B |
|
||
|
Inhibrx Biosciences, Inc. Common Stock
|
89.83
|
-0.74% |
145.42K |
1.32B |
|
||
|
Oric Pharmaceuticals, Inc. Common Stock
|
12.35
|
-3.29% |
945.34K |
1.28B |
|
||
|
Tyra Biosciences, Inc. Common Stock
|
18.52
|
-2.73% |
648.95K |
1.27B |
|
||
|
GH Research PLC Ordinary Shares
|
18.15
|
-3.51% |
162.60K |
1.25B |
|
||
|
First Tracks Biotherapeutics, Inc. Ordinary Shares
|
34.46
|
-4.38% |
1.04M |
1.23B |
|
||
|
Nektar Therapeutics
|
35.78
|
-5.14% |
783.88K |
1.22B |
|
||
|
Kardigan, Inc. Common Stock
|
13.03
|
-6.12% |
717.61K |
1.22B |
|
||
|
LB Pharmaceuticals Inc Common Stock
|
36.74
|
+0.14% |
724.73K |
1.19B |
|
||
|
Taysha Gene Therapies, Inc. Common Stock
|
3.62
|
-2.95% |
2.75M |
1.18B |
|
||
|
Omeros Corporation
|
16.20
|
-13.78% |
3.96M |
1.17B |
|
||
|
Syndax Pharmaceuticals, Inc.
|
12.90
|
-5.49% |
2.84M |
1.15B |
|
||
|
Damora Therapeutics, Inc. Ordinary Shares
|
18.44
|
-1.60% |
836.71K |
1.14B |
|
||
|
Alpha Tau Medical Ltd. Ordinary Shares
|
12.29
|
-6.61% |
778.49K |
1.14B |
|
||
|
Iambic Therapeutics, Inc. Common Stock
|
23.81
|
+0.00% |
2.94M |
1.13B |
|
||
|
Bicara Therapeutics Inc. Common Stock
|
16.78
|
-4.77% |
819.73K |
1.11B |
|
||
|
Nanobiotix S.A. American Depositary Shares
|
21.30
|
-4.18% |
77,772 |
1.08B |
|
||
|
Vor Biopharma Inc. Common Stock
|
18.03
|
-6.77% |
733.08K |
1.07B |
|
||
|
Avalyn Pharma Inc. Common Stock
|
23.66
|
-3.98% |
291.43K |
1.05B |
|
||
|
Immatics N.V. Ordinary Shares
|
6.73
|
-5.74% |
1.15M |
1.02B |
|
||
|
Replimune Group, Inc.
|
10.86
|
-7.57% |
1.71M |
1.02B |
|
||
|
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
6.79
|
-3.96% |
2.22M |
1.01B |
|
||
|
Janux Therapeutics, Inc. Common Stock
|
16.51
|
-4.68% |
765.88K |
1.01B |
|
||
|
Mannkind Corporation
|
3.04
|
-4.70% |
2.61M |
977.50M |
|
||
|
Seaport Therapeutics, Inc. Common Stock
|
17.83
|
+1.31% |
184.54K |
954.45M |
|
||
|
Latigo Biotherapeutics, Inc. Common Stock
|
14.00
|
-5.15% |
207.38K |
928.19M |
|
||
|
Savara Inc.
|
4.45
|
-6.12% |
2.23M |
914.30M |
|
||
|
MeiraGTx Holdings plc Ordinary Shares
|
9.28
|
-6.17% |
666.43K |
891.28M |
|
||
|
Alto Neuroscience Inc.
|
21.94
|
-3.01% |
648.32K |
860.97M |
|
||
|
Rigel Pharmaceuticals Inc. (New)
|
45.97
|
-2.71% |
141.43K |
858.71M |
|
||
|
SL Science Holding Limited Ordinary Shares
|
1.53
|
-1.29% |
24,822 |
857.96M |
|
||
|
Jade Biosciences, Inc. Common Stock
|
13.47
|
-2.11% |
980.98K |
856.66M |
|
||
|
Aktis Oncology, Inc. Common stock
|
15.06
|
-5.93% |
394.80K |
837.63M |
|
||
|
Arbutus Biopharma Corporation Common Stock
|
4.22
|
-1.63% |
4.54M |
836.01M |
|
||
|
Cullinan Therapeutics, Inc. Common Stock
|
12.93
|
-7.64% |
1.12M |
832.11M |
|
||
|
Monte Rosa Therapeutics, Inc. Common Stock
|
9.74
|
-3.75% |
883.19K |
830.95M |
|
||
|
Odyssey Therapeutics, Inc. Common Stock
|
17.17
|
-2.28% |
218.38K |
825.16M |
|
||
|
ArriVent BioPharma, Inc. Common Stock
|
16.66
|
-0.77% |
1.33M |
821.47M |
|
||
|
MoonLake Immunotherapeutics Class A Ordinary Shares
|
9.55
|
-6.92% |
1.38M |
812.77M |
|
||
|
Kura Oncology, Inc.
|
9.08
|
-6.39% |
1.78M |
807.76M |
|
||
|
SpyGlass Pharma, Inc. Common Stock
|
24.00
|
-2.91% |
70,647 |
802.75M |
|
||
|
Corvus Pharmaceuticals, Inc.
|
9.52
|
-3.35% |
1.04M |
800.83M |
|
||
|
Ardelyx, Inc.
|
3.09
|
-5.50% |
5.78M |
797.80M |
|
||
|
Alumis Inc. Common Stock
|
6.12
|
-3.01% |
2.50M |
792.14M |
|
||
|
Verastem, Inc.
|
8.65
|
-6.28% |
6.09M |
783.37M |
|
||
|
Helus Pharma Inc.
|
10.55
|
-4.52% |
1.31M |
770.88M |
|
||
|
Geron Corp
|
1.17
|
-4.88% |
3.95M |
751.69M |
|
||
|
Apnimed, Inc. Common Stock
|
17.76
|
-2.66% |
235.05K |
739.36M |
|
||
|
Obsidian Therapeutics, Inc. Common Stock
|
11.77
|
-3.52% |
297.68K |
727.07M |
|
||
|
Adlai Nortye Group Ltd. American Depositary Shares
|
11.03
|
-8.77% |
336.59K |
710.31M |
|
||
|
Inventiva S.A. American Depository Shares
|
2.94
|
-5.47% |
4.85M |
694.53M |
|
||
|
Ginkgo Bioworks Holdings, Inc.
|
10.27
|
-12.67% |
3.55M |
691.58M |
|
||
|
Sana Biotechnology, Inc. Common Stock
|
2.27
|
-8.28% |
3.09M |
679.55M |
|
||
|
Lexicon Pharmaceuticals, Inc.
|
1.52
|
-7.88% |
2.01M |
676.33M |
|
||
|
4D Molecular Therapeutics, Inc. Common Stock
|
12.14
|
-5.67% |
794.53K |
670.66M |
|
||
|
OmniAb, Inc. Common Stock
|
4.59
|
-2.96% |
969.41K |
667.34M |
|
||
|
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
9.36
|
-2.80% |
9,029 |
662.48M |
|
||
|
Immix Biopharma, Inc. Common Stock
|
7.98
|
-8.06% |
1.47M |
661.57M |
|
||
|
Achieve Life Sciences, Inc.
|
6.38
|
-8.46% |
1.99M |
657.79M |
|
||
|
MiMedx Group, Inc
|
4.43
|
-5.34% |
2.73M |
646.49M |
|
||
|
Annexon, Inc. Common Stock
|
3.41
|
-5.28% |
5.11M |
646.46M |
|
||
|
Design Therapeutics, Inc. Common Stock
|
10.31
|
-1.62% |
854.55K |
645.22M |
|
||
|
Gyre Therapeutics, Inc. Common Stock
|
6.08
|
-5.00% |
142.87K |
644.69M |
|
||
|
Aura Biosciences, Inc. Common Stock
|
6.10
|
-3.79% |
762.44K |
632.60M |
|
||
|
Prime Medicine, Inc. Common Stock
|
3.47
|
-3.88% |
4.38M |
629.38M |
|
||
|
Attovia Therapeutics, Inc. Common Stock
|
13.73
|
-7.10% |
977.90K |
626.79M |
|
||
|
Candel Therapeutics, Inc. Common Stock
|
8.19
|
-8.08% |
1.50M |
626.69M |
|
||
|
Wave Life Sciences Ltd. Ordinary Shares
|
3.13
|
-1.88% |
3.28M |
616.76M |
|
||
|
Nuvectis Pharma, Inc. Common Stock
|
18.60
|
-1.74% |
158.42K |
607.18M |
|
||
|
Avalo Therapeutics, Inc. Common Stock
|
11.27
|
-6.16% |
969.41K |
604.41M |
|
||
|
Solid Biosciences Inc. Common Stock
|
5.53
|
-3.66% |
1.40M |
592.96M |
|
||
|
Zevra Therapeutics, Inc. Common Stock
|
9.94
|
-3.21% |
593.88K |
590.27M |
|
||
|
Olema Pharmaceuticals, Inc. Common Stock
|
6.58
|
-4.22% |
1.08M |
575.73M |
|